Hainan Huluwa Pharmaceutical Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 430.41 million compared to CNY 527.26 million a year ago. Revenue was CNY 430.41 million compared to CNY 527.26 million a year ago.

Net income was CNY 29.03 million compared to CNY 40.56 million a year ago. Basic earnings per share from continuing operations was CNY 0.07 compared to CNY 0.1 a year ago. Diluted earnings per share from continuing operations was CNY 0.07 compared to CNY 0.1 a year ago.